Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3559-3567, July 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wondergem, J.
Right arrow Articles by Bull, J. M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wondergem, J.
Right arrow Articles by Bull, J. M. C.

Effect of Adriamycin Combined with Whole Body Hyperthermia on Tumor and Normal Tissues1

Jan Wondergem2, L. Clifton Stephens, Frederick R. Strebel, Hideo Baba3, Shinji Ohno3, Zahid H. Siddik, Robert A. Newman and Joan M. C. Bull4

University of Texas Medical School at Houston, Department of Internal Medicine [J. W., F. R. S., H. B., S. O., J. M. C. B.], and M. D. Anderson Cancer Center, Departments of Veterinary Medicine [L. C. S.] and Medical Oncology [Z. H. S., R. A. N.], Houston, Texas 77030

Thermal enhancement of Adriamycin-mediated antitumor activity and normal tissue toxicities by whole body hyperthermia were compared using a F344 rat model. Antitumor activity was studied using a tumor growth delay assay. Acute normal tissue toxicities (i.e., leukopenia and thrombocytopenia) and late normal tissue toxicities (i.e., myocardial and kidney injury) were evaluated by functional/physiological assays and by morphological techniques. Whole body hyperthermia (120 min at 41.5°C) enhanced both Adriamycin-mediated antitumor activity and toxic side effects. The thermal enhancement ratio calculated for antitumor activity was 1.6. Thermal enhancement ratios estimated for "acute" hematological changes were 1.3, whereas those estimated for "late" damage (based on morphological cardiac and renal lesions) varied between 2.4 and 4.3. Thus, while whole body hyperthermia enhances Adriamycin-mediated antitumor effect, normal tissue toxicity is also increased, and the potential therapeutic gain of the combined modality treatment is eroded.

1 Supported by National Cancer Institute Grant RO1-CA-43090.

2 Present address: University Hospital Leiden, Department of Clinical Oncology, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands.

3 on leave from Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka 812, Japan.

4 To whom requests for reprints should be addressed.

Received 10/15/90. Accepted 4/22/91.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.